Moderna | MRNA - Market Capitalization

Stock Price
49.04
Daily Change
-0.99 -1.98%
Monthly
-10.31%
Yearly
97.26%
Q2 Forecast
48.05

Moderna reported $18.42B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
Arrowhead Research USD 9.7B 920M May/2026
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Celltrion KRW 42.71T 908.1B May/2026
Cspc Pharmaceutical CNY 87.29B 19.74B Dec/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.78B 215M Dec/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 600.53M 14.56M Dec/2025
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Moderna USD 20.15B 8.53B Mar/2026
Organigram Holdings CAD 312.16M 66.64M Dec/2025
Ovoca Bio EUR 6.12M 4.93M Apr/2026
Pharma Mar EUR 1.7B 128.17M May/2026
Qiagen NV USD 6.43B 1.85B May/2026
Regeneron Pharmaceuticals USD 81.68B 560M Mar/2026
Sarepta Therapeutics USD 2.16B 123M May/2026
Sartorius EUR 14.25B 2.16B Mar/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
United Therapeutics USD 28.08B 2.9B May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026
Zealand Pharma A/S 33.35B 448.34M Dec/2025